Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia‐targeted dose escalation
Abstract
Purpose: The goal of this article is to compute the cell survival during fractionated radiotherapy with non‐uniform hypoxia‐targeted dose distribution relative to cell survival for a uniform dose distribution with equal integral tumor dose. The analysis is performed for different parameters of radiotherapy with conventional and hypofractionated dose regimens. Methods: Our analysis is done using a parsimonious tumor response model that describes the major components of tumor response to radiotherapy such as radiosensitivity, cell proliferation, and hypoxia using as few variables as possible. Two levels of oxygenated and hypoxic cells with the survival curves described by the linear quadratic (LQ) model are implemented in the model. The model allows for analytical solutions for relative cell survival in a single fraction simulation which can be used for additional validation of our numerical simulations. The relative cell survival was computed for conventional and hypofractionated dose regimens in a model problem with radiobiological parameters for the non‐small‐cell lung cancer. Sensitivity of cell survival to different parameters of radiotherapy such as the relative volume of hypoxic fraction, boost dose ratio, re‐oxygenation rate, and delivery errors was investigated. Results: Our computational and analytical results show that relative cell survival for non‐uniform and uniform dose distributions is larger than 1.0 during the first few fractions of radiotherapy with conventional fractionation. This indicates that the uniform dose distribution produces a higher cell killing effect for the equal integral dose. This may stem from domination of linear contribution to the cell killing effect seen in the dose range of 1–2 Gy and a steeper slope of survival curve in the oxygenated tumor region. This effect can only happen if the distribution of clonogens is nearly uniform; therefore, after the first few fractions, the non‐uniform dose distributions outperform the uniform dose distribution and relative cell survival becomes less than 1.0. However, re‐oxygenation and delivery errors can also reduce the effectiveness of hypoxia‐targeted non‐uniform dose distributions toward the end of treatment. For hypofractionated radiotherapy with fractional dose >3 Gy, the relative cell survival was always below 1.0, which means the non‐uniform dose distributions produced higher cell killing effect than the uniform dose distribution during the entire treatment. Conclusion: The data obtained in this work suggest that non‐uniform hypoxia‐targeted dose distributions are less effective at cell killing than uniform dose distributions at the beginning of radiotherapy with conventional fractionation. However; non‐uniform dose distributions can outperform uniform dose distribution by the end of the treatment if the effects of re‐oxygenation and delivery errors are reduced. In hypofractionated radiotherapy, non‐uniform hypoxia‐targeted dose distributions are more efficient than uniform dose distributions during the entire treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fractionated radiotherapy can transform cancer cells in quiescent and hypoxic states into proliferating cancer cells with high oxygen content during the rest period, thereby increasing sensitivity to radiation.
“Fractionated radiotherapy can transform cancer cells in quiescent and hypoxic states into proliferating cancer cells with high oxygen content during the rest period of radiotherapy, thereby increasing the sensitivity to radiation. 359”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [359]
Cites
Reporting and analyzing dose distributions: A concept of equivalent uniform dose
Niemierko, A. (1997) · Medical Physics · doi:10.1118/1.598063 · Cited by 1,231 · see citing works
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562 · see citing works
Bradley, J. D., Graham, M. V., Winter, K. A., Purdy, J. A., Komaki, R. U., Roa, W., Ryu, J. K., Bosch, W. R., & Emami, B. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.260 · Cited by 438 · see citing works
Chao, K. S. C., Bosch, W. R., Mutic, S., Lewis, J. S., Dehdashti, F., Mintun, M. A., Dempsey, J. F., Pérez, C. A., Purdy, J. A., & Welch, M. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01433-4 · Cited by 429 · see citing works
Hypoxia Dose Painting by Numbers: A Planning Study
Thorwarth, D., Eschmann, S. M., Paulsen, F., & Alber, M. L. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.061 · Cited by 297 · see citing works
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288 · see citing works
Lee, N. Y., Mechalakos, J., Nehmeh, S. A., Lin, Z., Squire, O. D., Cai, S., Chan, K., Zanzonico, P. B., Greco, C., Ling, C. C., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.039 · Cited by 234 · see citing works
Hendrickson, K. R. G., Phillips, M. H., Smith, W. P., Peterson, L. M., Krohn, K., & Rajendran, J. G. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.029 · Cited by 189 · see citing works
Self-citationRadiobiology for the Radiologist
Gunn, W. G. (1988) · JAMA · doi:10.1001/jama.1988.03410110136047 · Cited by 147 · see citing works
Selective boosting of tumor subvolumes
Tomé, W. A., & Fowler, J. F. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00666-0 · Cited by 128 · see citing works
Rajendran, J. G., & Krohn, K. A. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.006 · Cited by 125 · see citing works
Self-citationPopple, R. A., Ove, R., & Shen, S. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03007-9 · Cited by 96 · see citing works
Søvik, Å., Malinen, E., Bruland, Ø. S., Bentzen, S. M., & Olsen, D. R. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/2/013 · Cited by 89 · see citing works
Chang, J. H., Wada, M., Anderson, N., Joon, D. L., Lee, S. T., Gong, S. J., Gunawardana, D. H., Sachinidis, J. I., O'Keefe, G. J., Gan, H. K., et al. (2013) · Acta Oncologica · doi:10.3109/0284186x.2012.759273 · Cited by 88 · see citing works
Adapting radiotherapy to hypoxic tumours
Malinen, E., Søvik, Å., Hristov, D. H., Bruland, Ø. S., & Olsen, D. R. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/51/19/012 · Cited by 79 · see citing works
Mayr, N. A., Huang, Z., Wang, J. Z., Lo, S. S.-M., Fan, J. M., Grecula, J. C., Sammet, S., Sammet, C. L., Jia, G., Zhang, J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.011 · Cited by 75 · see citing works
Webb, S., Evans, P., Swindell, W. H., & Deasy, J. O. (1994) · Physics in Medicine and Biology · doi:10.1088/0031-9155/39/11/018 · Cited by 59 · see citing works
Optimization of Human Cancer Radiotherapy
Swan, G. W. (1981) · Lecture notes in biomathematics · doi:10.1007/978-3-642-46441-6 · Cited by 58 · see citing works
Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response
Jeong, J., Shoghi, K. I., & Deasy, J. O. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/14/4897 · Cited by 55 · see citing works
Feasibility and sensitivity study of helical tomotherapy for dose painting plans
Deveau, M. A., Bowen, S. R., Westerly, D., & Jeraj, R. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.500302 · Cited by 45 · see citing works
Self-citationApplied Radiobiology and Bioeffect Planning
Dale, R. (2001) · Physics in Medicine and Biology · doi:10.1088/0031-9155/47/1/701 · Cited by 40 · see citing works
Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia
Ruggieri, R., Naccarato, S., & Nahum, A. E. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.486796 · Cited by 38 · see citing works
Functional and Molecular Image Guidance in Radiotherapy Treatment Planning Optimization
Das, S. K., & Haken, R. K. T. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.10.002 · Cited by 35 · see citing works
Chvetsov, A. V., Dong, L., Palta, J. R., & Amdur, R. J. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.007 · Cited by 29 · see citing works
Self-citationKim, Y., & Tomé, W. A. (2008) · Acta Oncologica · doi:10.1080/02841860701843050 · Cited by 29 · see citing works
The impact of hypofractionation on simultaneous dose‐boosting to hypoxic tumor subvolumes
Ruggieri, R., & Nahum, A. E. (2006) · Medical Physics · doi:10.1118/1.2358205 · Cited by 23 · see citing works
Time-dependent cell disintegration kinetics in lung tumors after irradiation
Chvetsov, A. V., Palta, J. J., & Nagata, Y. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/9/013 · Cited by 20 · see citing works
Self-citationNakamura, K., & Brahme, A. (1999) · PubMed · Cited by 17 · see citing works
Gago‐Arias, A., Aguiar, P., Espinoza, I., Sánchez-Nieto, B., & Pardo‐Montero, J. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/3/1204 · Cited by 15 · see citing works
Chvetsov, A. V., Sandison, G. A., Schwartz, J. L., & Rengan, R. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/21/8491 · Cited by 13 · see citing works
Self-citationAxente, M., Lin, P.-S., & Pugachev, A. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/9/2757 · Cited by 5 · see citing works
Keall, P., Vedam, S. S., Kini, V. R., Joshi, S. C., Tracton, G. S., & Mohan, R. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03609-x · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119 · see citing works
Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
Marcus, D., Lieverse, R. I. Y., Klein, C., Abdollahi, A., Lambin, P., Dubois, L. J., & Yaromina, A. (2021) · Cancers · doi:10.3390/cancers13061468 · Cited by 41 · see citing works
Forster, J. C., Marcu, L. G., & Bezak, E. (2019) · Physica Medica · doi:10.1016/j.ejmp.2019.07.006 · Cited by 25 · see citing works
Forster, J. C., Douglass, M. J. J., Phillips, W. M., & Bezak, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-54941-1 · Cited by 21 · see citing works
The importance of dead material within a tumour on the dynamics in response to radiotherapy
Lewin, T. D., Byrne, H. M., Maini, P. K., Caudell, J. J., Moros, E. G., & Enderling, H. (2019) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab4c27 · Cited by 17 · see citing works
Cerebral tissue oxygenation response to brain irradiation measured during clinical radiotherapy
Myllylä, T., Korhonen, V. O., Karthikeyan, P., Honka, U., Lohela, J., Inget, K., Ferdinando, H., Karhula, S. S., & Nikkinen, J. (2023) · Journal of Biomedical Optics · doi:10.1117/1.jbo.28.1.015002 · Cited by 12 · see citing works
Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer
Kuperman, V. Y., & Lubich, L. M. (2020) · Medical Physics · doi:10.1002/mp.14343 · Cited by 9 · see citing works
Hypoxia dose painting in SBRT – the virtual clinical trial approach
Schiavo, F., Toma-Daşu, I., & Lindblom, E. K. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2258272 · Cited by 8 · see citing works
Volume dependence in hypoxia‐targeted dose escalation
Chvetsov, A. V., Zeng, J., & Rajendran, J. G. (2018) · Medical Physics · doi:10.1002/mp.13176 · Cited by 7 · see citing works
Self-citationBarrett, S., Hanna, G. G., & Marignol, L. H. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.029 · Cited by 5 · see citing works
Nano-haemoglobin-based oxygen carrier increases the radiosensitivity of non-small-cell lung cancer
Liu, C., Li, Y., Feng, S., Lv, X., Li, F., Wong, B., Liu, J., & Yang, C. (2025) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2025.2503369 · Cited by 1 · see citing works
Chvetsov, A. V., & Pugachev, A. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad87f8 · Cited by 1 · see citing works
Self-citationTumor Models for Optimization of Radiotherapy Response
Chvetsov, A. V. (2025) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-96-7001-7_2
Self-citationDose Nonuniformity Effectiveness
Chvetsov, A. V. (2025) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-96-7001-7_5
Self-citation
- Authors
- Chvetsov, A. V., Rajendran, J. G., Zeng, J., Patel, S. A., Bowen, S. R., & Kim, E. Y.
- Affiliations
- University of Washington (US)
- Corresponding author
- Chvetsov, Alexei V.
- Venue
- Medical Physics
- Publisher
- Wiley
- Published
- 2017-03-28
- Volume
- 44
- Issue
- 5
- Pages
- 1975-1982
- ISSN
- 0094-2405 (ISSN-L)
- 2473-4209
- OpenAlex
- W2590984159
- Cited by
- 14
- References
- 32
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Physics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- fractionated radiotherapy, hypofractionated radiotherapy, cell survival, linear-quadratic model, dose escalation, reoxygenation, delivery errors, non-small cell lung cancer, radiosensitivity, cell proliferation, hypoxic fraction, tumor control probability
- MeSH terms
- Hypoxia, Carcinoma, Non-Small-Cell Lung, Cell Survival, Humans, Lung Neoplasms, Models, Biological, Radiobiology, Tumor Cells, Cultured, Dose Fractionation, Radiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review